Log in or Sign up for Free to view tailored content for your specialty!
Infection News
Much still to discover on role of gut microbiome in immune system
There is a complex interplay between the immune system and the gut microbiota, according to a review published in Nutrients.
Gut: Opinions vary on potential effect on immune system
I hope everyone is safe and well. The delta virus peak is surging in the Upper Midwest. Hopefully we will get a bit of a reprieve in the new year.
Log in or Sign up for Free to view tailored content for your specialty!
Large proportion of undiagnosed anti-HDV positive individuals due to lack of testing
Hepatitis D, in hepatitis B surface antigen-positive individuals, may remain undiagnosed due to lack of testing, particularly in primary care settings, according to a poster.
VIDEO: Microbiome therapeutics promising for recurrent C. difficile
In this video, Jessica R. Allegretti, MD, MPH, discussed a presentation from the ACG Annual Scientific Meeting that provided an overview of microbiome therapeutics currently under investigation for Clostridioides difficile infection.
VIDEO: SER-109 may represent ‘paradigm shift’ in management of recurrent C. difficile
Jessica R. Allegretti, MD, MPH, spoke with Healio about a study demonstrating the efficacy of SER-109 in preventing recurrent Clostridioides difficile infection, including in patients using acid-suppressing medications.
VIDEO: CP101 increased microbiome diversity, reduced recurrent C. difficile
In this video, Jessica R. Allegretti, MD, MPH, discussed findings from the PRISM3 trial evaluating an investigational therapeutic for the prevention of recurrent Clostridioides difficile infection.
App could predict viral diarrhea in children
A new mobile health app for doctors could predict viral diarrhea in children, according to findings from a study presented recently at the American Society of Tropical Medicine & Hygiene Annual Meeting.
VIDEO: ‘Excellent data’ on investigational microbiome therapy for recurrent C. difficile
In this video, C. Jonathan D. Foster, DO, FACOI, discusses results from the PRISM3 trial assessing CP101, an investigational microbiome therapeutic, for recurrent Clostridioides difficile infection.
VIDEO: Vonoprazan-based therapy promising for H. pylori eradication
In this video, C. Jonathan D. Foster, DO, FACOI, discussed a study on the use of vonoprazan-based regimens for the treatment of Helicobacter pylori infection presented at the ACG Annual Scientific Meeting.
VIDEO: Examining yield of H. pylori biopsies after negative tests
C. Jonathan D. Foster, DO, FACOI, spoke with Healio about the utility of repeat Helicobacter pylori biopsies in patients with previously negative tests.
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read
-
Headline News
Rise in alcohol use during pandemic endures as 'an alarming public health issue'
November 14, 20242 min read -
Headline News
AI identified patient messages sent by proxies, but also broke confidentiality
November 14, 20242 min read -
Headline News
Diabetes inequities persist worldwide, especially for low-, middle-income countries
November 14, 20243 min read